Lestaurtinib
≥99%
- Product Code: 101210
CAS:
111358-88-4
| Molecular Weight: | 439.46 g./mol | Molecular Formula: | C₂₆H₂₁N₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Lestaurtinib is primarily investigated for its potential in treating various types of cancer, particularly acute myeloid leukemia (AML) and myeloproliferative disorders. It functions as a tyrosine kinase inhibitor, targeting and blocking specific enzymes that promote cancer cell growth and survival. This mechanism makes it a candidate for combination therapies with other chemotherapeutic agents to enhance treatment efficacy. Additionally, lestaurtinib is being studied for its role in managing solid tumors and its potential to overcome drug resistance in certain cancers. Research also explores its application in reducing inflammation and fibrosis in non-cancerous conditions, leveraging its inhibitory effects on kinase pathways involved in these processes. Clinical trials continue to evaluate its safety, dosage, and effectiveness in diverse therapeutic contexts.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | ฿26,235.00 |
+
-
|
| 0.005 | 10-20 days | ฿77,220.00 |
+
-
|
Lestaurtinib
Lestaurtinib is primarily investigated for its potential in treating various types of cancer, particularly acute myeloid leukemia (AML) and myeloproliferative disorders. It functions as a tyrosine kinase inhibitor, targeting and blocking specific enzymes that promote cancer cell growth and survival. This mechanism makes it a candidate for combination therapies with other chemotherapeutic agents to enhance treatment efficacy. Additionally, lestaurtinib is being studied for its role in managing solid tumors and its potential to overcome drug resistance in certain cancers. Research also explores its application in reducing inflammation and fibrosis in non-cancerous conditions, leveraging its inhibitory effects on kinase pathways involved in these processes. Clinical trials continue to evaluate its safety, dosage, and effectiveness in diverse therapeutic contexts.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :